3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Prostatic Neoplasms
2
Motor Activity
2
Breast Neoplasms
2
Urologic Neoplasms
1
Testicular Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Sarcoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Rectal Neoplasms
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Neuromuscular Diseases
1
Neoplasm Metastasis
1
Myotonic Dystrophy
1
Myositis, Inclusion Body
1
Muscular Dystrophy, Facioscapulohumeral
1
Muscular Dystrophies, Limb-Girdle
1
Muscular Atrophy, Spinal
1
Multiple Myeloma
1
Lymphoma, B-Cell
1
Lymphedema
1
Lung Neoplasms
1
Low Anterior Resection Syndrome
1
Lambert-Eaton Myasthenic Syndrome
1
Kidney Neoplasms
1
Hereditary Sensory and Motor Neuropathy
1
Guillain-Barre Syndrome
1
Interventions
Vincristine
13
Temozolomide
12
Cyclophosphamide
11
Irinotecan
8
Magnetic Resonance Spectroscopy
7
X-Rays
6
Vinorelbine
6
Specimen Handling
6
Phantoms, Imaging
6
Dactinomycin
6
Biopsy
5
fludarabine
4
Radiotherapy
4
Radiation
4
Nuclear Medicine Department, Hospital
4
Filgrastim
4
Etoposide
4
pegfilgrastim
3
irinotecan sucrosofate
3
Sirolimus
3
Proton Therapy
3
Melphalan
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Physical Therapy Modalities
×
1 year
×
Clear all
No trials found.